Primary signet-ring cell carcinoma of the extrahepatic bile duct: A case report

Table 1 Summary of reported cases of signet ring cell carcinoma of extrahepatic bile duct

Ref.	Age	Sex	Location	TNM1	Treatment	Outcome
Lee et al[7], 2010	55	M	Distal	T3N1M0	Resection; Chemoradiation	Alive at 24 mo
Ogata et al[8], 2010	42	F	Distal	T4N1M0	Resection	Alive at 6 mo
Somer et al[9], 2012	66	F	Perihilar	T3N0M0	Resection	No described
Kita et al[10], 2014	73	F	Distal	T3N0M0	Resection; Gemcitabine/cisplatin	Alive at 12 mo
Kwon et al[11], 2014	63	M	Distal	T3N0M0	Resection	Dead at 15 mo
Hua et al[12], 2015	52	M	Distal	T4N1M0	Resection	Dead at 6 mo
Chedid et al[13], 2015	66	F	Perihilar	T4N0M0	Resection	Dead at 15 mo
Zhang et al[14], 2018	32	F	Distal	T3N1M0	Resection	Dead at 5 mo
Welsh et al[15], 2018	55	F	Distal	T3N1M0	Chemoradiation	Dead at 4 mo
Hameed et al[16], 2019	72	F	Distal	T1N0M0	Resection	No described
Ghoddoosi et al[17], 2021	68	F	Perihilar	T1N0M0	Gemcitabine/cisplatin	Alive at 9 mo
Present case	82	F	Distal	T3N1M1	PTCD	Dead at 1 mo

¹AJCC Cancer Staging Manual, 8^th edition.

PTCD: Percutaneous transhepatic cholangiopancreatic drainage.